financetom
Business
financetom
/
Business
/
BRIEF-Acceler8 Ventures Cancels Proposed Acquisition Of Verifyyed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Acceler8 Ventures Cancels Proposed Acquisition Of Verifyyed
Jun 17, 2025 8:54 AM

June 17 (Reuters) - Acceler8 Ventures PLC:

* ACCELER8 VENTURES - CESSATION OF ACQUISITION

* ACCELER8 VENTURES PLC - CANCELS PROPOSED ACQUISITION OF

VERIFYYED

* ACCELER8 VENTURES PLC: CONTINUES TO SEEK ALTERNATIVE

TARGETS,

EVALUATING A NUMBER OF NEW OPPORTUNITIES

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports
Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports
Oct 10, 2025
(Reuters) -Johnson & Johnson ( JNJ ) is in discussions to buy Protagonist Therapeutics ( PTGX ), the Wall Street Journal reported on Friday, citing people familiar with the matter. A deal is not guaranteed and the exact details being discussed could not be learned, the newspaper said. The two companies are already working together on an oral treatment for...
BHP Resumes China Iron Ore Sales: Report
BHP Resumes China Iron Ore Sales: Report
Oct 10, 2025
BHP Group Limited ( BHP ) has resumed iron ore sales into China, quelling speculation that Beijing had restricted purchases from the world's top producer. According to Reuters, the move followed reports of several cargoes being offered to buyers after China's week-long national holiday. Market sources reported that a 170,000-metric-ton shipment was sold to a Chinese trading house on Thursday,...
BRIEF-Bristol Myers Squibb To Acquire Orbital Therapeutics
BRIEF-Bristol Myers Squibb To Acquire Orbital Therapeutics
Oct 10, 2025
Oct 10 (Reuters) - Bristol-Myers Squibb Co ( BMY ): * BRISTOL MYERS SQUIBB STRENGTHENS AND DIVERSIFIES CELL THERAPY PORTFOLIO WITH ACQUISITION OF ORBITAL THERAPEUTICS * BRISTOL-MYERS SQUIBB CO ( BMY ) - BMS TO PAY $1.5 BILLION IN CASH FOR ORBITAL Source text: Further company coverage: ...
Market Chatter: Johnson & Johnson in Talks to Acquire Protagonist Therapeutics
Market Chatter: Johnson & Johnson in Talks to Acquire Protagonist Therapeutics
Oct 10, 2025
11:28 AM EDT, 10/10/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) is in talks to acquire Protagonist Therapeutics ( PTGX ) , The Wall Street Journal reported Friday, citing people familiar with the matter. Johnson & Johnson ( JNJ ) and Protagonist did not immediately reply to requests for comment from MT Newswires. (Market Chatter news is derived...
Copyright 2023-2026 - www.financetom.com All Rights Reserved